Grantham, Mayo, Van Otterloo & Co (GMO)’s Neenah, Inc. Common Stock NP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-20,359
Closed -$695K 824
2022
Q2
$695K Sell
20,359
-10,200
-33% -$382K ﹤0.01% 567
2022
Q1
$1.21M Sell
30,559
-6,600
-18% -$282K 0.01% 507
2021
Q4
$1.72M Sell
37,159
-2,300
-6% -$113K 0.01% 485
2021
Q3
$1.84M Hold
39,459
0.01% 470
2021
Q2
$1.98M Buy
39,459
+3,200
+9% +$171K 0.01% 467
2021
Q1
$1.86M Sell
36,259
-9,641
-21% -$536K 0.01% 489
2020
Q4
$2.54M Sell
45,900
-35,900
-44% -$1.65M 0.02% 392
2020
Q3
$3.06M Buy
81,800
+30,700
+60% +$1.38M 0.02% 329
2020
Q2
$2.53M Buy
51,100
+44,000
+620% +$2.12M 0.02% 365
2020
Q1
$306K Buy
+7,100
New +$420K ﹤0.01% 656

Other funds holding NP

Grantham, Mayo, Van Otterloo & Co (GMO)'s NP Position: Q3 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Neenah, Inc. Common Stock (NP) in Q3 2022, closing a stake of 20,359 shares — an estimated $695K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NP in Q1 2020 and held it in 10 quarters. The position peaked at $3.06M in Q3 2020. 2 funds tracked by Wall St. Rank hold NP as of Q3 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Neenah, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 20,359 Neenah, Inc. Common Stock shares in Q3 2022, an estimated $695K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Neenah, Inc. Common Stock in Q1 2020 and held it in 10 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Neenah, Inc. Common Stock position peaked at $3.06M in Q3 2020.
  • 2 funds tracked by Wall St. Rank held Neenah, Inc. Common Stock as of Q3 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.